Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MST1R | Q04912 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TGM2 | P21980 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6319359 | 1.00 | MEN1 (0.39) | MEN1NPC1RAB9AKMT2AIDO1 | |
| SCHEMBL6319632 | 0.94 | MEN1 (0.38) | MEN1NPC1RAB9AKMT2AIDO1 | |
| SCHEMBL6319638 | 0.94 | MEN1 (0.38) | MEN1NPC1RAB9AKMT2AIDO1 | |
| SCHEMBL6319734 | 0.92 | ALDH1A1 (0.39) | MEN1NPC1RAB9AKMT2AIDO1 | |
| SCHEMBL6319743 | 0.92 | ALDH1A1 (0.39) | MEN1NPC1RAB9AKMT2AIDO1 | |
| SCHEMBL6328091 | 0.90 | IDO1 (0.41) | MEN1NPC1RAB9AKMT2AIDO1 | |
| SCHEMBL6328087 | 0.90 | IDO1 (0.41) | MEN1NPC1RAB9AKMT2AIDO1 | |
| SCHEMBL4493761 | 0.90 | CCNB2 (0.35) | POLBALDH1A1HPGDMST1RLMNA | |
| SCHEMBL4493758 | 0.90 | CCNB2 (0.35) | POLBALDH1A1HPGDMST1RLMNA | |
| SCHEMBL30979372 | 0.90 | CCNB2 (0.35) | POLBALDH1A1HPGDMST1RLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0973855-B1 | BLEACH COMPOSITIONS CONTAINING METAL BLEACH CATALYST, AND BLEACH ACTIVATORS AND/OR ORGANIC PERCARBOXYLIC ACIDS | PROCTER & GAMBLE (US) | 2003-08-06 | — | — | EP | claimed |
| EP-1322739-B1 | GRANULATED COMPOSITION | GIVAUDAN SA (CH) | 2005-11-30 | — | — | EP | disclosed |
| US-20050250667-A1 | Effervescent granulated composition | GIVAUDAN SA (CH) | 2005-11-10 | — | — | US | disclosed |
| US-6855710-B2 | Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2005-02-15 | — | — | US | disclosed |
| EP-1470210-A1 | EFFERVESCENT GRANULATED COMPOSITION | Givaudan SA (CH) | 2004-10-27 | — | — | EP | disclosed |
| US-20040115231-A1 | Granulated composition | HART GERALD LESLIE (GB) | 2004-06-17 | — | — | US | disclosed |
| US-20040058978-A1 | Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2004-03-25 | — | — | US | disclosed |
| WO-2003064579-A1 | EFFERVESCENT GRANULATED COMPOSITION | GIVAUDAN SA (CH) | 2003-08-07 | — | — | WO | disclosed |
| US-6602441-B1 | Activators for peroxy compounds in laundry detergents and cleaning products | CLARIANT GMBH (DE) | 2003-08-05 | — | — | US | disclosed |
| EP-1322739-A2 | GRANULATED COMPOSITION | Givaudan SA (CH) | 2003-07-02 | — | — | EP | disclosed |
| EP-1115704-B1 | NOVEL SUBSTITUTED INDOLINONES WITH AN INHIBITORY EFFECT ON VARIOUS KINASES AND CYCLIN/CDK COMPLEXES | BOEHRINGER INGELHEIM PHARMA (DE) | 2003-06-18 | — | — | EP | disclosed |
| WO-2002024847-A2 | GRANULATED COMPOSITION | GIVAUDAN SA (CH) | 2002-03-28 | — | — | WO | disclosed |
| US-6139769-A | CONTACTING A SUBSTRATE WITH AN AQUEOUS SOLUTION COMPRISING A PEROXIDE AND A METAL COMPLEX BLEACH ACTIVATOR FOR LAUNDERING AND CLEANING | CLARIANT GMBH (DE) | 2000-10-31 | — | — | US | disclosed |
| US-5998645-A | LAUNDERING DETERGENTS; CLEANING COMPOUNDS | CLARIANT GMBH (DE) | 1999-12-07 | — | — | US | disclosed |
| US-5969171-A | Metal complexes as bleach activators | CLARIANT GMBH (DE) | 1999-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058978-A1 | Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs | CDK1, CDK2, CDK3 | MEN1 3345/4885NPC1 4477/4885RAB9A 2092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.